World Investment Advisors LLC Makes New Investment in National Health Investors, Inc. (NYSE:NHI)

World Investment Advisors LLC bought a new position in shares of National Health Investors, Inc. (NYSE:NHIFree Report) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 14,795 shares of the real estate investment trust’s stock, valued at approximately $1,244,000.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of NHI. Blue Trust Inc. raised its stake in National Health Investors by 2,651.9% during the 2nd quarter. Blue Trust Inc. now owns 743 shares of the real estate investment trust’s stock worth $47,000 after buying an additional 716 shares during the period. Sumitomo Mitsui Trust Holdings Inc. raised its holdings in National Health Investors by 16.0% in the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 472,959 shares of the real estate investment trust’s stock valued at $32,034,000 after acquiring an additional 65,104 shares during the period. Lee Danner & Bass Inc. acquired a new position in shares of National Health Investors in the second quarter valued at about $5,089,000. International Assets Investment Management LLC acquired a new stake in shares of National Health Investors during the 2nd quarter worth $36,000. Finally, Van ECK Associates Corp increased its stake in shares of National Health Investors by 6.9% in the 2nd quarter. Van ECK Associates Corp now owns 6,404 shares of the real estate investment trust’s stock valued at $434,000 after purchasing an additional 416 shares during the last quarter. 62.51% of the stock is owned by institutional investors.

National Health Investors Stock Performance

NYSE NHI opened at $72.76 on Monday. The company has a 50-day simple moving average of $77.01 and a two-hundred day simple moving average of $75.53. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors, Inc. has a 12-month low of $51.59 and a 12-month high of $86.13. The firm has a market cap of $3.30 billion, a price-to-earnings ratio of 25.00, a PEG ratio of 4.87 and a beta of 1.04.

National Health Investors (NYSE:NHIGet Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). The business had revenue of $63.32 million for the quarter, compared to analysts’ expectations of $67.93 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The company’s revenue was up 1.7% on a year-over-year basis. During the same period last year, the business earned $1.08 earnings per share. On average, equities analysts forecast that National Health Investors, Inc. will post 4.42 EPS for the current year.

National Health Investors Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be given a $0.90 dividend. This represents a $3.60 annualized dividend and a dividend yield of 4.95%. The ex-dividend date is Tuesday, December 31st. National Health Investors’s dividend payout ratio is presently 123.71%.

Wall Street Analysts Forecast Growth

Several equities analysts have issued reports on NHI shares. StockNews.com cut shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th. Truist Financial lifted their price target on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a report on Friday, August 30th. Wells Fargo & Company downgraded National Health Investors from an “overweight” rating to an “equal weight” rating and increased their target price for the stock from $81.00 to $86.00 in a research report on Tuesday, October 1st. Finally, Bank of America started coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price target for the company. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $76.33.

Read Our Latest Stock Report on National Health Investors

About National Health Investors

(Free Report)

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Featured Articles

Want to see what other hedge funds are holding NHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Health Investors, Inc. (NYSE:NHIFree Report).

Institutional Ownership by Quarter for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.